NCT01471639View on ClinicalTrials.gov

An Efficacy and Safety Trial of Intranasal Ketorolac in Emergency Department Patients for the Treatment of Acute Pain

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Other Acute Pain
Interventions
DRUG

intranasal ketorolac

15 mg

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

Sponsors

Collaborators (1)

American Regent, Inc.
All Listed Sponsors
collaborator

American Regent, Inc.

INDUSTRY

lead

The Cleveland Clinic

OTHER